TFs like Tbx-1, CP2, and PLAGL2 have also been confirmed to be involved in the expression of thyroid cancer, colorectal cancer, and gastric cancer [31, 32], respectively, and they might be key targets for cancer treatment. Here, PLAGL2 is linked to gastric cancer.